Biochimica et Biophysica Acta-Reviews on Cancer

Papers
(The TQCC of Biochimica et Biophysica Acta-Reviews on Cancer is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Immunotherapy for HPV negative head and neck squamous cell carcinoma308
SENP3: Cancers and diseases223
Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma211
PAK2 as a therapeutic target in cancer: Mechanisms, challenges, and future perspectives209
Research progress of mitochondria and cytoskeleton crosstalk in tumour development184
Adipose tissue-to-breast cancer crosstalk: Comprehensive insights130
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy129
A comprehensive review of current therapeutic strategies in cancers targeting DNA damage response mechanisms in head and neck squamous cell cancer109
New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer105
Retraction notice to “Coagulation and inflammation in cancer: Limitations and prospects for treatment” [Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877 (2022) 188727]101
Glioblastoma preclinical models: Strengths and weaknesses93
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate88
Editorial Board88
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications87
Extrachromosomal DNA: Redefining the pathogenesis of glioblastoma82
Exploration of tumor penetrating peptide iRGD as a potential strategy to enhance tumor penetration of cancer nanotherapeutics75
Ponatinib: An update on its drug targets, therapeutic potential and safety75
Editorial Board71
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective70
Cancer stem cell in prostate cancer progression, metastasis and therapy resistance69
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors66
Editorial Board63
Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy59
Tumor microenvironment crosstalk between tumors and the nervous system in pancreatic cancer: Molecular mechanisms and clinical perspectives58
Adenosine in cancer immunotherapy: Taking off on a new plane57
Lymphatic vasculature in ovarian cancer55
Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives54
An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies53
Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells52
Tumoral heterogeneity in neuroblastoma50
The naked translation in cancer49
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents49
Time to abandon CAR-T monotherapy for solid tumors45
Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy43
New insights into RAS in head and neck cancer43
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models43
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy43
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance42
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment41
New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies41
Targeting nanoparticles to malignant tumors38
Advances in epigenetic modifications and cervical cancer research37
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer37
The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis37
Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review36
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine36
Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance36
Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis35
The role of the NDRG1 in the pathogenesis and treatment of breast cancer35
New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research35
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?35
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p5334
Nutrition and dietary restrictions in cancer prevention34
ETS transcription factors: Multifaceted players from cancer progression to tumor immunity34
Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care34
Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity33
T cell exhaustion in human cancers32
The potential of methioninase for cancer treatment32
Genomic instability, inflammatory signaling and response to cancer immunotherapy31
The role of m6A modification in pediatric cancer31
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer31
A Darwinian perspective on tumor immune evasion31
The role of 5-HT metabolism in cancer30
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy29
ESR1 activating mutations: From structure to clinical application29
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review29
Targeting protein kinases benefits cancer immunotherapy29
The overall process of metastasis: From initiation to a new tumor28
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics28
Expression and function of NF-Y subunits in cancer27
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy27
N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy27
The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity27
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance27
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy27
Histone deacetylase complexes: Structure, regulation and function26
Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients26
Targeting autophagy in urological system cancers: From underlying mechanisms to therapeutic implications25
Drivers of cancer metastasis – Arise early and remain present25
The interaction of SET and protein phosphatase 2A as target for cancer therapy25
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids25
Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights25
Mitochondria: The metabolic switch of cellular oncogenic transformation24
Combinatorial therapy in tumor microenvironment: Where do we stand?24
Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer24
Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer24
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response24
Delivery routes matter: Safety and efficacy of intratumoral immunotherapy24
The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence23
Improving DCIS diagnosis and predictive outcome by applying artificial intelligence23
Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target23
A digital highway for data fluidity and data equity in precision medicine23
Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer23
Metastasis prevention: How to catch metastatic seeds22
miRNAs and androgen deprivation therapy for prostate cancer22
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment22
Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma22
An overview of the research progress of BRCA gene mutations in breast cancer22
Uveal melanoma modeling in mice and zebrafish22
Understanding and advancement in gold nanoparticle targeted photothermal therapy of cancer22
The RNA m6A writer METTL14 in cancers: Roles, structures, and applications21
Editorial Board21
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants21
Targeting ion channels for the treatment of lung cancer21
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy21
Editorial Board21
Progress and challenges of immunotherapy in triple-negative breast cancer21
The tumor microenvironment's gambit: Exosomal pawns on the board of head and neck cancer21
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer21
The roles of small extracellular vesicles in lung cancer: Molecular pathology, mechanisms, diagnostics, and therapeutics20
An overview of kinin mediated events in cancer progression and therapeutic applications20
S100A8 and S100A9 in Cancer20
Oncoviruses: How do they hijack their host and current treatment regimes20
Editorial Board20
Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer20
Vitamin K: New insights related to senescence and cancer metastasis20
Recent advances in HDAC-targeted imaging probes for cancer detection20
Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars20
Targeting Trop-2 in cancer: Recent research progress and clinical application20
Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles20
Editorial Board19
Dissecting SOX2 expression and function reveals an association with multiple signaling pathways during embryonic development and in cancer progression19
Find the path of least resistance: Adaptive therapy to delay treatment failure and improve outcomes19
Regulation of cGAS-STING signalling in cancer: Approach for combination therapy19
Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence19
The intratumoural microbiota in cancer: new insights from inside19
Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?19
Helicobacter pylori triggers inflammation and oncogenic transformation by perturbing the immune microenvironment19
Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma19
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.19
Advances in nuclei targeted delivery of nanoparticles for the management of cancer19
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications19
Tumor-associated neutrophils and neutrophil-targeted cancer therapies19
CDK7-dependent transcriptional addiction in bone and soft tissue sarcomas: Present and Future19
Role of exosomes in lung cancer: A comprehensive insight from immunomodulation to theragnostic applications19
Leveraging preclinical models of metastatic breast cancer18
Roles of CDK12 mutations in PCa development and treatment18
Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors18
Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression18
Promises of natural products as clinical applications for cancer18
How to evaluate deep learning for cancer diagnostics – factors and recommendations17
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors17
Precision oncology: Using cancer genomics for targeted therapy advancements17
Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma17
Corrigendum to “Recent thymic emigrants as the bridge between thymoma and autoimmune diseases” [Biochim Biophys Acta Rev Cancer. 2022;1877(3):188730.]17
Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy17
Decoding mitochondria's role in immunity and cancer therapy17
Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells17
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model16
Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications16
Targeting Bcl-2 for cancer therapy16
RORγT agonists as immune modulators in anticancer therapy.16
Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets15
Breaking through therapeutic barriers: Insights into CDK4/6 inhibition resistance in hormone receptor-positive metastatic breast cancer15
PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway15
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase15
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways15
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies15
Ability of animals to detect cancer odors15
Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis15
Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence15
Finding the junction between claudins and endometrial carcinoma15
Keep a watchful eye on methionine adenosyltransferases, novel therapeutic opportunities for hepatobiliary and pancreatic tumours15
The potential roles of p53 signaling reactivation in pancreatic cancer therapy15
0.14958882331848